331 related articles for article (PubMed ID: 30300140)
1. Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
Kim TH; Yang YM; Han CY; Koo JH; Oh H; Kim SS; You BH; Choi YH; Park TS; Lee CH; Kurose H; Noureddin M; Seki E; Wan YY; Choi CS; Kim SG
J Clin Invest; 2018 Dec; 128(12):5587-5602. PubMed ID: 30300140
[TBL] [Abstract][Full Text] [Related]
2. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
3. Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome.
Kors L; Rampanelli E; Stokman G; Butter LM; Held NM; Claessen N; Larsen PWB; Verheij J; Zuurbier CJ; Liebisch G; Schmitz G; Girardin SE; Florquin S; Houtkooper RH; Leemans JC
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1883-1895. PubMed ID: 29514047
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
[TBL] [Abstract][Full Text] [Related]
5. Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid β-oxidation.
Seok S; Kim YC; Byun S; Choi S; Xiao Z; Iwamori N; Zhang Y; Wang C; Ma J; Ge K; Kemper B; Kemper JK
J Clin Invest; 2018 Jul; 128(7):3144-3159. PubMed ID: 29911994
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.
Shin SY; Kim TH; Wu H; Choi YH; Kim SG
Eur J Pharmacol; 2014 Mar; 727():115-24. PubMed ID: 24486702
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
[TBL] [Abstract][Full Text] [Related]
9. Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.
Xu F; Gao Z; Zhang J; Rivera CA; Yin J; Weng J; Ye J
Endocrinology; 2010 Jun; 151(6):2504-14. PubMed ID: 20339025
[TBL] [Abstract][Full Text] [Related]
10. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
11. Gα13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism.
Koo JH; Kim TH; Park SY; Joo MS; Han CY; Choi CS; Kim SG
J Clin Invest; 2017 Oct; 127(10):3845-3860. PubMed ID: 28920922
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis associated with decreased β-oxidation and mitochondrial function contributes to cell damage in obese mice after thermal injury.
Diao L; Auger C; Konoeda H; Sadri AR; Amini-Nik S; Jeschke MG
Cell Death Dis; 2018 May; 9(5):530. PubMed ID: 29748608
[TBL] [Abstract][Full Text] [Related]
13. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte miR-33a mediates mitochondrial dysfunction and hepatosteatosis by suppressing NDUFA5.
Nie H; Yu X; He H; Zhou L; Li Q; Song C; Wang D; Ren T; Chen Z; Huang H; Dai X; Zhou Y
J Cell Mol Med; 2018 Dec; 22(12):6285-6293. PubMed ID: 30324697
[TBL] [Abstract][Full Text] [Related]
15. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
Purushotham A; Schug TT; Xu Q; Surapureddi S; Guo X; Li X
Cell Metab; 2009 Apr; 9(4):327-38. PubMed ID: 19356714
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin ligase Grail promotes hepatic steatosis through Sirt1 inhibition.
Liu PY; Chen CC; Chin CY; Liu TJ; Tsai WC; Chou JL; Huang CY; Chen YG; Chen YC
Cell Death Dis; 2021 Mar; 12(4):323. PubMed ID: 33771967
[TBL] [Abstract][Full Text] [Related]
19. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.
Sun Y; Xia M; Yan H; Han Y; Zhang F; Hu Z; Cui A; Ma F; Liu Z; Gong Q; Chen X; Gao J; Bian H; Tan Y; Li Y; Gao X
Br J Pharmacol; 2018 Jan; 175(2):374-387. PubMed ID: 29065221
[TBL] [Abstract][Full Text] [Related]
20. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
